Cargando…
Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnost...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394832/ https://www.ncbi.nlm.nih.gov/pubmed/37538313 http://dx.doi.org/10.3389/fmed.2023.1171023 |
_version_ | 1785083457257340928 |
---|---|
author | Shao, Guangzhao Zhi, Yao Fan, Zhongqi Qiu, Wei Lv, Guoyue |
author_facet | Shao, Guangzhao Zhi, Yao Fan, Zhongqi Qiu, Wei Lv, Guoyue |
author_sort | Shao, Guangzhao |
collection | PubMed |
description | BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnostic and prognostic nomograms specifically tailored for LM in HCC patients. METHODS: A retrospective analysis was conducted on HCC patients from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2015. The study employed multivariate logistic regression analysis to identify risk factors associated with LM in HCC patients. Additionally, multivariate Cox proportional hazards regression analysis was utilized to investigate prognostic factors for HCC patients with LM. Subsequently, two nomograms were developed to predict the risk and prognosis of LM in HCC patients. The performance of the nomograms was evaluated through calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULT: This retrospective study included a total of 5,934 patients diagnosed with HCC, out of which 174 patients were diagnosed with LM. Through multivariate logistic regression analysis, several independent risk factors for LM in HCC patients were identified, including tumor grade, tumor size, American Joint Committee for Cancer (AJCC) T stage, and AJCC N stage. Furthermore, multivariate Cox analysis revealed that tumor grade, delayed treatment, surgery, and radiation were independent prognostic factors for HCC patients with LM. To assess the predictive power of the developed nomograms, calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) were employed. The findings demonstrated that the nomograms exhibited satisfactory performance in both the training and validation sets. Additionally, the prognostic nomogram effectively stratified HCC patients with LM into low- and high-risk groups for mortality. CONCLUSION: These two nomograms optimally predicted the risk and prognosis of LM in HCC patients. Both nomograms have satisfactory performance. This would help clinicians to make accurate clinical decisions. |
format | Online Article Text |
id | pubmed-10394832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103948322023-08-03 Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database Shao, Guangzhao Zhi, Yao Fan, Zhongqi Qiu, Wei Lv, Guoyue Front Med (Lausanne) Medicine BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnostic and prognostic nomograms specifically tailored for LM in HCC patients. METHODS: A retrospective analysis was conducted on HCC patients from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2015. The study employed multivariate logistic regression analysis to identify risk factors associated with LM in HCC patients. Additionally, multivariate Cox proportional hazards regression analysis was utilized to investigate prognostic factors for HCC patients with LM. Subsequently, two nomograms were developed to predict the risk and prognosis of LM in HCC patients. The performance of the nomograms was evaluated through calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULT: This retrospective study included a total of 5,934 patients diagnosed with HCC, out of which 174 patients were diagnosed with LM. Through multivariate logistic regression analysis, several independent risk factors for LM in HCC patients were identified, including tumor grade, tumor size, American Joint Committee for Cancer (AJCC) T stage, and AJCC N stage. Furthermore, multivariate Cox analysis revealed that tumor grade, delayed treatment, surgery, and radiation were independent prognostic factors for HCC patients with LM. To assess the predictive power of the developed nomograms, calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) were employed. The findings demonstrated that the nomograms exhibited satisfactory performance in both the training and validation sets. Additionally, the prognostic nomogram effectively stratified HCC patients with LM into low- and high-risk groups for mortality. CONCLUSION: These two nomograms optimally predicted the risk and prognosis of LM in HCC patients. Both nomograms have satisfactory performance. This would help clinicians to make accurate clinical decisions. Frontiers Media S.A. 2023-07-19 /pmc/articles/PMC10394832/ /pubmed/37538313 http://dx.doi.org/10.3389/fmed.2023.1171023 Text en Copyright © 2023 Shao, Zhi, Fan, Qiu and Lv. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Shao, Guangzhao Zhi, Yao Fan, Zhongqi Qiu, Wei Lv, Guoyue Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title | Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title_full | Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title_fullStr | Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title_full_unstemmed | Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title_short | Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database |
title_sort | development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the seer database |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394832/ https://www.ncbi.nlm.nih.gov/pubmed/37538313 http://dx.doi.org/10.3389/fmed.2023.1171023 |
work_keys_str_mv | AT shaoguangzhao developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase AT zhiyao developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase AT fanzhongqi developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase AT qiuwei developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase AT lvguoyue developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase |